Melinta Therapeutics LLC
- Address
- 389 Interpace Parkway Suite 450
Sponsor Overview
Specializations
Paediatric Infectious Disease
Melinta Therapeutics LLC focuses on clinical research in acute bacterial skin and skin structure infections affecting children, with attention to treatment options for paediatric patients requiring hospital-based care.
- Acute ABSSSI
- Paediatric infection management
- Skin and soft tissue infections
The sponsor’s research activity is centred on evaluating intravenous anti-infective therapy in a multinational network of sites.
Antibacterial Therapy
The clinical programme includes interest in oritavancin for bacterial skin infections, reflecting a therapeutic emphasis on gram-positive bacterial coverage and treatment of serious skin and skin structure infections.
- Oritavancin
- Intravenous antibacterial treatment
- Gram-positive pathogens
This area aligns with the sponsor’s work in developing therapies for infections that require effective systemic antibacterial intervention.
Hospital and Acute Care Infections
Research activity is directed toward infections managed in acute care settings, with clinical interest in patients presenting with skin and soft tissue bacterial disease that may need prompt treatment and monitoring.
- Acute care infection treatment
- Hospital-based infectious disease care
- Systemic bacterial infections
The sponsor’s trial footprint spans multiple collaborating sites across several countries, supporting investigation of infection therapies in varied clinical environments.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety and Tolerability of Single-Dose Intravenous Oritavancin Versus Standard Care in Pediatric Acute Bacterial Skin and Skin Structure Infections |  Bulgaria Greece Latvia Lithuania Poland Portugal Romania Spain | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 23 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
23 centres- Address
- Zemgales Priekspilseta, Vienibas Gatve 45, 1004 Riga
- Address
- Viestura Iela 5, 5401 Daugavpils
- Address
- Paseo De La Castellana 261, 28046 Madrid
- Address
- Ring Road Of Thessaloniki, Ministry Of Pavlos Melas, 564 29 Thessaloniki
- Address
- Rua Mario Botas 1, 1998-018 Lisbon
- Address
- Estrada Forte Do Alto Duque, 1449-005 Lisbon
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Melinta Therapeutics LLC.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.